/Companies

Oncolyze

New York, US · Delaware corporation

Find your way into Oncolyze

Sign up to see every warm intro you have to Oncolyze

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncolyze team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BC
Barbara CarlinNamed on SEC filing
SJ
Steven J. EvansNamed on SEC filing
RM
Rosemary MazanetNamed on SEC filing
AZ
Alexander ZukiwskiNamed on SEC filing
AS
Aleksandar StojanovicNamed on SEC filing
JF
James FoghtNamed on SEC filing
LA
Larry AltstielNamed on SEC filing
JA
John AbelesNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$425K disclosed across 1 round · 2022

▶$425KraisedJul 2022 · 4 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Barbara CarlinExecutive Officer
  • Steven J. EvansExecutive Officer, Director
  • Rosemary MazanetDirector
  • Alexander ZukiwskiDirector
  • Aleksandar StojanovicExecutive Officer
  • James FoghtDirector
  • Larry AltstielExecutive Officer
  • John AbelesDirector
Offering amount
$527.6K
Amount sold
$425K
Sales commissions
$51K
Placement agents
Ceros Financial Services, Inc.
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Oncolyze raised?
Oncolyze has disclosed $425K raised across 1 round.
Where is Oncolyze headquartered?
Oncolyze is headquartered in New York, US.